Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.
国药集团武汉血液制品有限公司

China

1 May 2019 - 30 April 2020

Principal institution: Beijing Tiantan Biological Products Co., Ltd.

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. published between 1 May 2019 - 30 April 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.27

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0.27

Top articles by Altmetric score in current window

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Proceedings of the National Academy of Sciences of the United States of America

2020-04-06

Return to institution outputs